An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

Pakistan, May 18 -- The first author is a Professor of English at Riphah International University, Lahore, and a lead guest editor at Emerald and Springer Publishing. The second author is an Assistant ...

Dan Fetsco, sponsor of the Pre-Law living learning community, poses with Resident Assistant Destiny Roberts, a 2026 Hall to Home Award winner. (Mollie Hand Photo) The University of Wyoming Learning ...

Language learning apps have changed how people study by making lessons flexible, affordable, and easy to access anywhere. Whether you want travel phrases, business fluency, or exam preparation, ...

If there's one thing the best running shoes for beginners shouldn't be, it's intimidating. That's because when you start running (or start to think about starting running), it can feel like stepping ...

AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...

NBC Select independently determines what we cover and recommend. When you click on or buy through our links, we earn a commission. Learn more. Ashley Morris Associate SEO Reporter As a serial hobbyist ...

A Revolution Medicines drug helped pancreatic cancer patients live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in this ...

If you've ever watched Ree Drummond whip up a comforting dinner and thought: "There's no way mine will turn out like that," you're not alone. The good news? Not every recipe requires years of kitchen ...

RAS Luxury Skincare has raised $7.5 Mn (about ₹68.7 Cr) in its Series B funding round led by Dabur Ventures, with participation from existing investor Unilever Ventures The fresh capital will be used ...

In the previous edition of my newsletter, I shared why I started my journey in Data Science and Machine Learning. As I continue learning, I realized that one of the most common questions beginners ...